TruSight One Sequencing Panels enable labs to expand and streamline their sequencing portfolio, while managing costs.
Two panels offer options to target up to 6700 genes associated with human disease, with high coverage
Single assay includes multiple genes of interest, replacing iterative testing
Easy, flexible gene filtering and annotation options simplify biological interpretation and reporting
These panels provide clinical research labs with an affordable solution for managing a diverse assay portfolio. The TruSight One Sequencing Panel provides comprehensive coverage of > 4800 disease-associated genes, while the TruSight One Expanded Sequencing Panel targets ~1900 additional genes with recent disease associations in the scientific literature.
Investigators can choose to analyze all of the genes on the panel or focus on a specific subset. With a single assay, labs can expand existing menus, streamline workflows, or create an entire portfolio of sequencing options.